We are excited to announce that Mr. Carlton Holmes has officially joined Stonehaven, LLC as Managing Director of Affiliate Partner Group, Engild Private Capital.

Carlton Holmes is a Managing Director at Engild Private Capital who works closely with Engild’s founder and Managing Partner, Alan Fields, CFA, CAIA. Prior to Engild Private Capital, Mr. Holmes was a principal at TACK37 Consulting where he provided consulting services to consumer goods companies, specializing in marketing and sales. Prior to TACK37 Consulting, Mr. Holmes was Vice President of OTC Marketing for Taro Pharmaceuticals where he grew an entire portfolio of profitable OTC generic/private label products. Prior to Taro Pharmaceuticals, Mr. Holmes was a Group Product Manager at Block Drug. Prior to Block Drug, Mr. Holmes served as a Product Manager for Johnson & Johnson.

Mr. Holmes received his MBA with a concentration in Marketing & Finance from Columbia Business School and he received his BA with a major in Mathematics and a minor in Economics from Cornell University. Mr. Holmes served as a Board Member of the Sag Harbor Hills Improvement Association.Mr. Holmes is currently pursuing the Series 7 and 63 registrations with FINRA.

About Stonehaven, LLC Stonehaven is an industry leading global placement agent focused on hedge funds, private equity, real estate, venture capital, private placements, and long‐only strategies.  Stonehaven’s platform serves as a nexus between select investment opportunities and the institutional investment community with a talented capital raising team and robust infrastructure. The Firm’s dynamic structure fosters an ever‐ evolving stable of distinctive managers to match the demand across the diverse investor community. Founded in 2001 by CEO David Frank, the Firm is entirely management owned, giving it complete independence to continue pursuing its entrepreneurial approach while maintaining the highest ethical and regulatory standards.